Katsushi Takahashi

Summary

Affiliation: Teijin Institute for Bio-Medical Research
Country: Japan

Publications

  1. ncbi 1 alpha,25-dihydroxyvitamin D3 suppresses interleukin-1beta-induced interleukin-8 production in human whole blood: an involvement of erythrocytes in the inhibition
    Katsushi Takahashi
    Pharmaceuticals Development Laboratories, Teijin Institute for Bio Medical Research, Hino, Tokyo, Japan
    Immunopharmacol Immunotoxicol 24:1-15. 2002
  2. ncbi Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha,25-dihydroxyvitamin D3
    Katsushi Takahashi
    Pharmaceuticals Development Laboratories, Teijin Institute for Bio Medical Research, Hino, Tokyo, Japan
    Immunopharmacol Immunotoxicol 24:335-47. 2002

Detail Information

Publications2

  1. ncbi 1 alpha,25-dihydroxyvitamin D3 suppresses interleukin-1beta-induced interleukin-8 production in human whole blood: an involvement of erythrocytes in the inhibition
    Katsushi Takahashi
    Pharmaceuticals Development Laboratories, Teijin Institute for Bio Medical Research, Hino, Tokyo, Japan
    Immunopharmacol Immunotoxicol 24:1-15. 2002
    ..These results suggest that erythrocytes play a role in mediating the inhibitory effects of 1,25(OH)2D3 on IL-8 production in IL-1beta-stimulated whole blood...
  2. ncbi Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha,25-dihydroxyvitamin D3
    Katsushi Takahashi
    Pharmaceuticals Development Laboratories, Teijin Institute for Bio Medical Research, Hino, Tokyo, Japan
    Immunopharmacol Immunotoxicol 24:335-47. 2002
    ..Under the same conditions, interleukin-1beta expression was also inhibited. These findings suggest that 1,25(OH)2D3 has a potential to affect the inflammatory process by modulating the expression of neutrophil genes...